4/19/2021  4:00:20 PM Chg. -0.2800 Volume Bid7:50:22 PM Ask7:50:22 PM Market Capitalization Dividend Y. P/E Ratio
43.4100EUR -0.64% 2,706
Turnover: 118,088.4100
43.4200Bid Size: 500 43.6600Ask Size: 500 9.97 bill.EUR - -

Business description

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).
 

Management board & Supervisory board

CEO
Thierry Bernard
Management board
Roland Sackers, Dr. Barthold Piening, Dr. Jonathan Sheldon, Dr. Thomas Schweins, Jean-Pascal Viola, Stephany Foster
Supervisory board
Lawrence A. Rosen, Dr. Metin Colpan, Dr. Toralf Haag, Elizabeth E. Tallett, Prof. Dr. Elaine Mardis, Prof. Dr. Ross L. Levine, Stéphane Bancel, Thomas Ebeling
 

Company data

Name: QIAGEN N.V.
Address: Spoorstraat 50,NL-5911 KJ Venlo
Phone: +31-77-320-8400
Fax: +31-77-320-8409
E-mail: qiagen@qiagen.com
Internet: www.qiagen.com
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 65.30%
IPO date: 9/25/1997

Investor relations

Name: John Gilardi
IR phone: +49-2103-29-11711
IR Fax: -
IR e-mail: john.gilardi@qiagen.com

Main Shareholders

Freefloat
 
65.30%
BlackRock, Inc.
 
15.00%
Sun Life Financial, Inc.
 
5.50%
Davidson Kempner Capital Management LP
 
4.20%
Farallon Capital Management LP
 
3.60%
State Street Corp.
 
3.30%
The Vanguard Group, Inc.
 
3.10%
Others
 
0.00%